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Summary 
Unplanned intensive care admission is a devastating complication of lung resection and is associated 
with significantly increased mortality. We carried out a two-year retrospective national multicentre 
cohort study to investigate the influence of anaesthetic and analgesic techniques on the need for 
unplanned postoperative intensive care admission. All patients undergoing lung resection surgery in 
16 thoracic surgical centres in the UK in the calendar years 2013 and 2014 were included.  Critical 
care admission was defined as the unplanned need for either tracheal intubation and mechanical 
ventilation or renal replacement therapy. Association was sought between mode of anaesthesia 
(total intravenous anaesthesia vs. volatile) and analgesic technique (epidural vs. paravertebral) and 
need for intensive care admission. A total of 253 out of 11,208 patients undergoing lung resection in 
the study period were admitted unplanned to intensive care in the postoperative period, giving an 
incidence of ICU admission of 2.3% (95% CI 2.0-2.6%). In patients admitted unplanned to ICU, 
mortality was higher (29.00% vs. 0.03%, p<0.001) and hospital stay was increased (26 vs. 6 days, 
p<0.001). Across univariate, complete-case and multiple imputation (multivariate) models there was 
a strong and significant effect of both anaesthetic and analgesic technique on the need for critical 
care admission. Patients receiving total intravenous anaesthesia (OR 0.50 (95% CI 0.34-0.70)), and 
patients receiving epidural analgesia (OR 0.56 (95% CI 0.41-0.78)) were less likely to be admitted 
unplanned to intensive care after thoracic surgery. This large retrospective study suggests a 
significant effect of both anaesthetic and analgesic technique on outcome in patients undergoing 
lung resection. We must emphasise that the observed association does not directly imply causation 
and suggest that well-conducted, large-scale randomised controlled trials are required to address 
these fundamental questions. 
  
Introduction 
Lung cancer is the second most common cancer in the UK and the leading cause of cancer death. In 
suitable cases, the best chance of ‘cure’ is surgery. Patients undergoing lung resection are often 
elderly and have underlying cardiorespiratory comorbidities leading to a high risk of peri-operative 
complications, many of which necessitate intensive care unit (ICU) admission after surgery. Whilst 
there has been a great deal of research focusing on specific postoperative complications following 
lung resection e.g. atrial fibrillation or lung injury, the population requiring unplanned ICU admission 
have received relatively little attention.  
Unplanned ICU admission (as distinguished from elective admission in extremely high-risk patients 
or after extensive surgery) is generally accepted to be associated with a marked increase in 
mortality, especially if due to respiratory compromise requiring tracheal re-intubation and 
mechanical ventilation of the lungs [1]. Whilst acute kidney injury therapy following thoracic surgery 
is also associated with increased rates of reintubation and prolonged hospital stay [2], in one 
historical cohort the combination of needing mechanical ventilation and renal replacement therapy 
was described as “universally fatal” underscoring the high risk of poor outcome in this patient group 
[1]. 
Following a successful single centre pilot study [3], we decided to undertake a multicentre 
retrospective study, co-ordinated by the Association of Cardiothoracic Anaesthesia and Critical Care 
(ACTACC) to examine unplanned ICU admission following lung resection over a period of two years. 
The study had three main aims. Firstly, we sought to characterise this population, by providing an 
up-to-date estimate of the incidence of unplanned ICU admission, describing the demographics of 
the patients requiring critical care and recording the indication for escalating support. Secondly, we 
sought to assess the burden of disease by recording ICU and hospital stay, resource use, mortality 
and post-ICU outcomes. Finally, and the principle focus of this manuscript, we sought to identify the 
effect of a number of peri-operative exposures of interest on the need for postoperative ICU 
admission. The optimal method of providing both general anaesthesia and postoperative analgesia 
to patients undergoing lung resection has long been the subject of much study and debate.  
Therefore, we investigated the potential influences of anaesthetic and analgesic technique on the 
incidence of postoperative ICU admission in patients undergoing lung resection surgery.  
Methods 
The study was a conducted as a multicentre retrospective cohort study of all patients undergoing 
lung resection surgery in participating UK hospitals during the calendar years 2013 and 2014. As this 
was an audit of routinely collected data for the National Health Service (NHS) in the UK, waiver of 
the need for research ethics committee approval was confirmed on behalf of the National Research 
Ethics Committee. Individual participating centres obtained local hospital approval as required. 
Consent for analysis of data was obtained from London School of Hygiene and Tropical Medicine 
Research Ethical Committee. 
All thoracic surgical centres in the UK and Ireland were invited to apply through the ACTACC 
‘Linkman programme’, through word of mouth and by direct advertising at ACTACC scientific 
congresses. A total of 16 centres out of 34 agreed to take part and provided data. With a 
methodology similar to the successful Royal College of Anaesthetists National Audit Projects [4], we 
asked centres to provide data on a numerator (patients admitted to ICU following lung resection) 
and denominator (all patients undergoing lung resection not admitted to ICU) basis. For the 
purposes of the study, intensive care admission (the numerator) was defined as “unplanned ICU 
admission and need for invasive mechanical ventilation and/or renal replacement therapy”, 
intentionally excluding patients admitted to ICU on a precautionary basis but ultimately not 
requiring ICU interventions, or those simply nursed in ICU for logistical reasons. Patients whose 
tracheas were not extubated immediately following surgery and transferred to the ICU for 
mechanical ventilation and postoperative care were included as ‘unplanned ICU admissions’ if 
postoperative mechanical ventilation was unplanned and the duration exceeded 12 hours. 
 A detailed dataset was recorded in each ‘case’ (patient satisfying the inclusion criteria as having an 
unplanned intensive care admission), containing baseline characteristics (including age, sex, 
resection type, operative side, pulmonary function test results, comorbidities and Thoracoscore [5]), 
anaesthetic and surgical technique, reason for admission and ICU outcomes. To allow calculation of 
an overall incidence of ICU admission, a denominator was sought which reflected the number of 
patients undergoing lung resection in a given centre during the study period. Given the retrospective 
nature of the study, and to avoid excessively burdening collaborators, data collection on this cohort 
was restricted to demographic data that was readily available. To allow exploration of the risk 
modifying effect of exposures of interest, investigators were also asked to provide a detailed dataset 
on a contemporaneous control group which included the five patients who underwent lung 
resection in each centre before each ICU admission. Data collection for this ‘detailed denominator’ 
dataset included age, sex, resection and side, pulmonary function test results, comorbidities, 
Thoracoscore and anaesthetic and surgical techniques.  
The incidence of ICU admission was calculated for each centre and the sample as a whole.  Individual 
centre estimates were compared with the overall incidence in the sample using a funnel plot with 
limits of agreement at two and three standard deviations from the overall incidence estimate [6]. 
Two separate models were initially fitted on complete records to investigate the association 
between the anaesthetic and analgesic techniques and odds of ICU admission. The crude effect of 
these techniques was first estimated with a univariate logistic regression model with only the 
variable of interest as the predictor variable. Secondly, remaining variables which could be 
associated with both the exposure of interest and the outcome, and with less than 20% missing 
records, were considered for inclusion as potential confounders in multivariate models. Each 
variable was first screened for univariate association between exposure of interest and ICU 
admission. Each model was then subsequently built using a forward approach, adjusting for one 
covariate at a time and looking at change in effect estimate. The covariate resulting in the greatest 
relative change of the log odds ratio for ICU admission was then added to the model. The process 
was repeated for each covariate showing univariate association, in order of decreasing strength of 
association. A 10% change in log odds was used as a cut-off point to determine which variables to 
keep in the model at each stage. Age and sex are known to play a role in a range of health outcomes 
therefore we chose to correct for them regardless of the univariate results.  
Finally, where candidate predictor variables of interest had over 20% missing values, we devised a 
multiple imputation by chained equations model. Ten imputations were deemed appropriate for 
minimal loss of power and efficiency. Functional form of the covariates in each model was tested by 
including age as a squared term; results from the likelihood ratio test comparing this to the model 
with linear age suggested that the square term does not provide additional benefit in terms of 
model fit (p>0.1 for all three models).  
The outcome modifying effect of anaesthetic and analgesic techniques is therefore presented as 
univariate, ‘adjusted complete case’ and ‘adjusted multiple imputation’ models. All data analysis was 
performed using STATA 15.0 Software (StataCorp LLC, Texas). 
  
Results 
A total of 11,208 patients underwent lung resection in the 16 collaborating centres during the study 
period, and 253 patients required unplanned ICU admission, resulting in an overall incidence of 2.3% 
(95%CI 2.0-2.6%). Visual analysis of the funnel plot displaying incidence of ICU admission against 
number of resections by centre (Figure 1) revealed no significant underperforming outliers amongst 
the 16 UK centres. Due to differences in the extent of audit data captured prospectively during the 
study period in each centre, some centres were able to provide detailed datasets on many more, if 
not all control patients, whilst others were only able to provide a detailed dataset in five 
contemporaneous controls following detailed retrospective case note reviews. Of the 11,208 
patients included in the study, substantial data was available for a total of 7,431 patients; 7,178 
controls and all 253 cases. Case-control data for these 7,431 patients was used for all other analyses. 
Demographic and surgical data for these patients are shown in Table 1. Patients admitted to ICU 
following lung resection were older, more likely to be female, were likely to have undergone more 
extensive lung resection and were less likely to have undergone video-assisted thoracoscopic 
surgery (VATS) compared with patients not admitted to ICU. Hospital stay and mortality were 
significantly increased in patients admitted to ICU (Table 1). 
The vast majority of patients admitted to ICU were admitted for mechanical ventilation (234, 94.7%) 
predominantly as a result of respiratory failure (171, 68.1%). The most common causes of 
respiratory failure were pulmonary infection (69, 27.3%) and sputum retention (39, 15.4%, (Table 
2)). Thirteen patients (5.3%) were admitted to ICU solely for renal replacement therapy. The median 
IQR [range]) duration of ICU stay was 12.5 (5-27 [0-88]) days; hospital stay was considerably 
prolonged in patients admitted to ICU who survived to hospital discharge. Hospital mortality in 
patients admitted to ICU was 29.0% (95% CI 23.2-35.3%), versus 0.03% (95% CI 0.01-0.10%), in 
patients not admitted to ICU (p<0.001).  
Data on the anaesthetic technique (volatile or total intravenous anaesthesia (TIVA)) were available 
for 4,070 control patients and 248 ICU cases. Following multivariate analysis, the odds of unplanned 
ICU admission postoperatively was less for patients receiving TIVA compared with those receiving a 
volatile anaesthetic (OR 0.50, 95%CI 0.34-0.70, Table 3). Sufficient data was available to allow 
multivariate adjustment for the potential confounding variables of age, sex, resection type, resection 
side and surgical approach (thoracotomy versus VATS). Resection side was not independently 
associated with the outcome or any of the exposures of interest and was excluded from the final 
models.  All other factors were independently associated with odds of ICU admission and were 
included in the adjusted compete-case analysis. Results of both the complete case analysis and the 
multiple imputation models supported the finding of a significant reduction in the odds of ICU 
admission with TIVA compared with volatile anaesthesia (Table 3). 
Data on the provision of regional anaesthesia was available for 3436 control patients and 247 ICU 
cases. Of these, 1540 patients received thoracic epidural blockade and 990 received paravertebral 
blockade. Of the remainder, 826 patients received no regional analgesic technique whilst 317 
patients received an ‘other’ technique. Analyses were performed to compare the influence of 
epidural and paravertebral blocks on the odds of unplanned ICU admission.  Following multivariate 
analysis, the odds of unplanned ICU admission were less for patients receiving epidural compared 
with paravertebral block (OR 0.56, 95%CI 0.41-0.78, Table 3), a finding which was again consistent 
across both complete case analysis and the multiple imputation models. 
Sensitivity analyses were performed comparing the incidence of ICU admission in patients 
undergoing lobectomy surgery only, via either a thoracotomy or VATS approach; the results of these 
are presented in Supplementary Tables S1 and S2. Following thoracotomy and lobectomy only, the 
results of these sensitivity analyses are supportive of the primary analysis demonstrating a 
consistent and significant reduction in the odds of unplanned ICU admission in patients receiving 
TIVA or epidural blockade. For patients undergoing VATS lobectomy only, the odds ratios appear 
consistent with those seen in the primary analysis, but the confidence intervals are broad and 
statistical significance is lost. This analysis however is confounded by the low number of patients 
requiring ICU admission following VATS surgery (28 of 1,146 VATS lobectomies within the study 
(2.4%)) and the low use of epidural use following VATS surgery (83 of 709 patients included in the 
univariate analysis of analgesic technique (11.7%)).  
  
Discussion 
This multicentre study is the largest to date examining ICU admission following lung resection (Table 
4). The reported incidence of unplanned ICU admission of 2.3% (95%CI 2.0-2.6%) compares 
favourably with previous reports where the incidence of ICU admission ranged from 2.6% to 25%. 
This may in part reflect the hard definition of ‘unplanned ICU admission’ used in the current study, 
which is likely to restrict ‘ICU cases’ to a more unwell cohort of patients than in previous reports, 
where patients admitted to the ICU on a precautionary basis are likely to have been included (Table 
4).  
Whilst only occurring in a small minority of patients, unplanned ICU admission was often prolonged, 
and was associated with markedly increased hospital stay and mortality. In the majority of cases, ICU 
admission necessitated mechanical ventilation due to respiratory complications. A number of 
strategies to prevent postoperative respiratory complications have been trialled in patients 
undergoing lung resection with limited success. Thoracic anaesthetists were early adopters of lung 
protective mechanical ventilation [7], though robust prospective data demonstrating an associated 
reduction in respiratory complications is still lacking. Oropharyngeal and nasopharyngeal 
decontamination with chlorhexidine gluconate had no effect on the incidence of respiratory 
infections in a recent multicentre French trial [8]. Whilst routine use of prophylactic non-invasive 
ventilation did not reduce the incidence of ‘acute respiratory events’ in high risk patients undergoing 
‘major lung resection’ [9], a reduction in hospital stay has been demonstrated following the 
prophylactic use of high flow nasal oxygenation as part of an enhanced recovery programme after 
lung resection surgery, although this study did not report the incidence of respiratory complications 
[10].  
The intriguing supposition of the current study is that routine anaesthetic and analgesic techniques 
may significantly influence the risk of ICU admission. Whilst historically, thoracic epidural blockade 
has been considered the gold standard method of providing postoperative analgesia for patients 
undergoing lung resection, anecdotal and published reports have documented a reduction in the use 
of epidurals and an increase in the use of paravertebrals [11]. Though a Cochrane review reported 
no difference between paravertebral and epidural in terms of death or major complications in 
patients undergoing thoracotomy [12], this trend towards paravertebral use has been fuelled by the 
parallel uptake of minimally-invasive VATS techniques and by observational reports [13], randomised 
controlled trials [14] and meta-analyses [15] suggesting an increased incidence of complications in 
patients receiving epidurals compared with paravertebrals. The current findings challenge these 
observations however, but as a retrospective analysis and can only indicate a possible association 
and not causation.  An imminent, large randomised controlled trial comparing epidural and 
paravertebral for the prevention of chronic pain in over 1000 patients undergoing lung resection by 
thoracotomy in the UK is in progress and should provide better data (TOPIC-2, ClinicalTrials.gov 
NCT03677856). 
Total intravenous anaesthesia use is ‘over-represented’ within thoracic surgery; in the Royal College 
of Anaesthetists’ Fifth National Audit Project Anaesthetic Activity Survey, 26% of thoracic 
anaesthetics used a TIVA technique compared with just 8% of the overall dataset (Personal 
communication, Dr M. Sury,  lead author of the NAP5 Anaesthetic Activity Survey [16]). This may 
reflect the theoretical benefits of TIVA to the thoracic anaesthetist in terms of preservation of 
hypoxic pulmonary vasoconstriction and the convenience of separating the provision of anaesthesia 
from airway maintenance and lung isolation [17]. Though a 2013 Cochrane review concluded “that 
no evidence indicated that the drug used to maintain anaesthesia during one-lung ventilation 
affected participant outcomes” [18] there is a significant body of randomised controlled trial data 
suggesting a reduced incidence of pulmonary inflammation and/or pulmonary complications in 
thoracic patients receiving volatile anaesthesia [19-21]. This is perceived to stem from an 
immunomodulatory effect of volatile anaesthesia [22]. Conversely, propofol is well recognised to 
have anti-oxidant properties both in vitro and in vivo, and there is a substantial animal literature 
supporting a protective effect of propofol in preventing lung injury via inhibition of oxidative stress 
mediated cellular damage [23,24].  
The apparently greater incidence in postoperative ICU admission in patients undergoing 
thoracotomy versus video assisted thoracoscopic (VATS) lung resection should be interpreted with 
caution; in a retrospective study of this sort it was impossible to identify which resections had begun 
via a VATS approach but had then undergone on the table conversion to thoracotomy, an instance 
which often occurs in the event of complications. Furthermore, patients identified as being suitable 
for VATS lung resection are often selected on the basis of favourable surgical anatomy and are likely 
therefore to be ‘systematically different’ to patients undergoing thoracotomy, potentially 
influencing their baseline risk of ICU admission.  
Missing data is a major challenge of retrospective research of this kind. In designing the study, a 
pragmatic line had to be drawn between the volume of data sought, and the practicalities of 
participating centres being able to provide this data. Many centres store large volumes of audit data 
prospectively and so were able to provide detailed control datasets on most patients, whilst others 
performed laborious case note reviews and so could only provide smaller and at times incomplete 
control datasets. We believe however that our statistical approach, in performing univariate, 
adjusted complete case and adjusted multiple imputation models robustly accounts for missing data. 
Indeed, the strong and consistent effect observed across all models in both the main and sensitivity 
analyses offers confidence in the result obtained. It remains possible that the ‘detailed denominator’ 
control group may not be representative of the UK thoracic surgical population as a whole, but by 
including in excess of 7,000 patients across 15 centres undergoing surgery contemporaneously to 
patients admitted to ICU we have we have sought to provide as large and generalisable control 
population as possible. 
Whilst, as discussed, the results presented have biological plausibility, the potential remains that 
unmeasured confounders could be responsible for the associations observed. Whilst patient age, 
sex, resection type and surgical approach were adjusted for, the potential effects of baseline 
(patient) risk, surgical factors, anaesthetist experience and case frequency, the use of lung protective 
ventilation, positive end-expiratory pressure and the conduct of one lung ventilation could not be 
accounted for. It is interesting to speculate on the potential influence of the thoracic anaesthetist, as 
choice of analgesic technique and mode of anaesthetic maintenance will on many occasions be an 
‘individual choice’. A recently published analysis, performed by ACTACC, examined the effect of 
individual patient risk, surgical centre, surgeon and anaesthetist on outcomes after cardiac surgery. 
This study reported that the principal component of variation in outcome was patient risk, that the 
impact of the surgeon and centre was moderate whereas the impact of the anaesthetist was 
negligible[25]. Whilst no such data is available for thoracic surgery, the widely perceived importance 
of fluid balance and the conduct of one-lung ventilation in dictating patient outcome could make 
anaesthetic factors more important determinants of outcome. As an alternative to the hypotheses 
that TIVA and TEB improve outcome due to biologically plausible clinical effects, one might speculate 
that at the time of this studies conduct, the ‘specialist’ thoracic anaesthetist may be more likely to 
choose TIVA, more confident in the practice of TEB in view of familiarity and has the potential to 
positively influence outcome.  
In conclusion, whilst the need for unplanned ICU admission following lung resection was rare, the 
consequences were considerable with markedly prolonged hospital stay and increased mortality, 
and significant implications for health care utilisation and cost. The current study reports in a large 
and nationally representative retrospective dataset, an apparently consistent protective effect of 
TIVA and epidural blockade in patients undergoing lung resection. Whilst this data challenges 
current trends in the practice of thoracic anaesthesia, the results have clear biological plausibility 
and mandate that we at least reconsider the less than definitive evidence base on which we base 
our current thoracic anaesthetic practices. The thoracic anaesthetic community must consider 
whether these age-old questions require further attention in the form of either large scale 
prospective audit or randomised controlled trials. 
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Table 1. Demographic and surgical details and outcomes of 7431 undergoing lung resection during 
the study period. Dichotomised by need for unplanned ICU admission. Values are mean (SD), 
number (proportion) or median (IQR [range]). 
 No ICU admission; n= 7178  ICU admission; n=253 p value  
Missing n 
 
 Missing n  
 
Age; years 0 7178 64.1 (13.2) 
 0 253 69.2 (9.4) 
<0.001 
         
Sex  1200  
 
 0   
 
 
Female  3092 51.7%   149 58.9% 0.025  
Male  2886 48.3%   104 41.1% 
 
         
Type of resection 551  
 
 0   
 
 Pneumonectomy  257 3.9%   25 9.88% <0.001 
 LVRS  25 0.4%   5 1.98%   
Lobectomy / 
bilobectomy  
3840 57.9%   192 75.5% 
 
 
Sub-lobar  2505 37.8%   31 12.65% 
 
         
Side of surgery 940    0     
Left  2549 40.9%   93 36.8% 0.356  
Right  3681 59.0%   160 63.2% 
 
 Bilateral  8 0.1%   0 0.0%  
         
Surgical technique 873    4    
 Open  3716 58.9%   204 81.9 <0.001 
 VATS  2589 41.0%   45 18.1  
          
Hospital stay 2057    27    
 Duration (days)  6 (4-8 [2-142]) 
   26 (13-45 
[0-129]) 
 <0.001 
          
Mortality 25    22   <0.001 
 Survivors  7151 99.5%   164 71%  
 Deceased  2 0.03%   67 29%  
LVRS, lung volume reduction surgery; VATS, video-assisted thoracoscopic surgery. 
 
  
Table 2. Indications for unplanned intensive care admission 
     ICU cases (N=253)        
   Missing n % 
Reason for ICU admission  6   
  Mechanical ventilation   181 73.3% 
  Renal replacement therapy   13 5.3% 
  Both   53 21.5% 
Primary admission diagnosis 2   
  Airway complication   15 6.0% 
  Acute Kidney Injury   13 5.2% 
  Anaphylaxis   0 0.0% 
  Bleeding   16 6.4% 
  Cardiac arrest   12 4.8% 
  Respiratory failure   171 68.1% 
  Sepsis   7 2.8% 
  Other   17 6.8% 
Perceived cause of respiratory failure 25   
  No respiratory failure   40 15.8% 
  ALI/ARDS   16 6.3% 
  Aspiration   5 2.0% 
  Broncho-pleural fistula   2 0.8% 
  Cardiac failure   6 2.4% 
  Infection   69 27.3% 
  Persistent air leak / surgical emphysema   17 6.7% 
  Pulmonary embolism   4 1.6% 
  Sputum retention   39 15.4% 
  Other   25 9.9% 
  Multiple causes   5 2.0% 
ALI, acute lung injury; ARDS, acute respiratory distress syndrome. 
  
Table 3. Influence of anaesthetic and analgesic technique on the odds of unplanned intensive care 
admission following lung resection. 
 
Model 
Exposure Univariate Adjusted complete-
case* 
Adjusted multiple 
imputation* 
N OR 95% CI N OR 95% CI N OR 95% CI 
Anaesthetic 
technique 
        - Volatile 
        - TIVA 
4,318  
 
1 
0.59 
 
 
 
(0.41-
0.83) 
3,683  
 
1 
0.46 
 
 
 
(0.32-
0.65) 
7,325  
 
1 
0.50 
 
 
 
(0.34-
0.70) 
Analgesic 
technique 
        - PVB 
        - Epidural 
 
3,683  
 
1 
0.77 
 
 
 
(0.57-
1.05) 
3,668  
 
1 
0.57 
 
 
 
(0.41-
0.78) 
7,431  
 
1 
0.56 
 
 
 
(0.41-
0.78) 
*Adjusted for age, sex, resection type, surgical approach 
 
Table 4: Studies reporting the incidence of ‘unplanned ICU admission following lung resection’. 
Author Year(s) of 
data 
collection 
Country No of ICU patients Incidence of 
ICU 
admission 
ICU / hospital 
mortality in 
ICU patients 
Inclusion criteria for ‘ICU cases’ 
Pilling et al. [1] 1998-2001 UK 28 7.1% 46% Salvage mechanical ventilation 
Brunelli et a. l[26] 2000-6 UK and 
Italy 
118 7.2% 36%* Major cardiopulmonary complications and 
receiving active life-supporting treatment 
Song et al. [27] 2001-5 Korea 94 8.6% 33% Signs of inadequate tissue perfusion, significant 
hemodynamic instability, requirement of invasive 
monitoring, use of inotropes, frequent 
nasotracheal suction, noninvasive ventilation, or 
mechanical ventilation 
Axelsson et al. [28]† 2001-10 Iceland 21 8% N/A Not defined 
Melley et al. [29] 2002-3 UK 52 30% 9.6% Not defined 
Okiror et al[. 30] 2003-8 UK 30 7% 17% Requiring ICU monitoring and/or treatment 
Petrella et al. [31]# 2004-11 Italy 29 11.6% 31% Urgent admission 
Pinheiro et al. [32] 2009-12 Brazil 30 25% 
(30/120)‡ 
N/A Mechanical ventilation or re-intubation, acute 
renal failure, shock or other complication  
Jung et al. [33] 2011-3 South 
Korea 
63 3.3% 25.4% Re-admission after initial recovery 
McCall et al. [3]¶ 2013-4 UK 30 2.6% 26.7% Unplanned ICU admission and need for invasive 
mechanical ventilation and/or renal replacement 
therapy 
Shelley et al. (ACTACC) 2018 UK 253 2.3%  35.6% Unplanned ICU admission and need for invasive 
mechanical ventilation and/or renal replacement 
therapy 
*Derived from a subset of 82 ICU patients in a ‘derivation dataset’. 
†Paper in Icelandic – data extracted from abstract only. 
#Pneumonectomy population only. 
‡Study tested a model for predicting need for ICU admission. In event, 25% clinically required ITU admission postoperatively. 
N/A – not reported, and not calculable from the data provided in the manuscript. 
¶This single-centre study was the pilot study for the current report – patients in this study are included in the current manuscript. 
 
 
